# VeraDermics (MANE) — Analyst Forecast

MANE · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/mane/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Jul 16, 2026 | Citigroup | Maintained | Buy | $160.00 |
| Jul 15, 2026 | B. Riley Securities | Initiated Coverage | Buy | $170.00 |
| Jul 15, 2026 | Needham | Maintained | Buy | $164.00 |
| Jul 7, 2026 | Jefferies | Maintained | Buy | $182.00 |
| Jun 16, 2026 | LifeSci Capital | Initiated Coverage | Outperform | $135.00 |
| Jun 2, 2026 | Needham | Initiated Coverage | Buy | $136.00 |
| May 18, 2026 | Citigroup | Maintained | Buy | $135.00 |
| Apr 22, 2026 | Leerink Partners | Maintained | Outperform | $90.00 |
| Mar 2, 2026 | Jefferies | Initiated Coverage | Buy | $75.00 |
| Mar 2, 2026 | Leerink Partners | Initiated Coverage | Outperform | $75.00 |
| Mar 2, 2026 | Citigroup | Initiated Coverage | Buy | $85.00 |
| Mar 2, 2026 | Cantor Fitzgerald | Initiated Coverage | Overweight | — |

## Frequently Asked Questions

### What is the latest analyst rating on MANE?

On Jul 16, 2026, Citigroup maintained VeraDermics at Buy with a price target of $160.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).